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Abstract
Background: Since the first suggestion of prospectively identifiable cancer stem cells in solid tumors, efforts have
been made to characterize reported cancer stem cell surrogates in existing cancer cell lines, and cell lines rich with
these surrogates have been used to screen for cancer stem cell targeted agents. Although 293T cells were derived
from human embryonic kidney, transplantation of these cells into the mammary fat pad yields aggressive tumors
that self-renew as evidenced by serial xenograft passages through transplantation. Herein we fully characterize
cancer stem cell-like features in 293T human embryonic kidney cells.
Results: 293T cells can be readily cultured and passaged as spheres in serum-free stem cell promoting culture
conditions. Cells cultured in vitro as three-dimensional spheres (3D) were shown to contain higher ALDH1 and
CD44+/CD24- population compared to monolayer cells. These cells were also resistant to radiation and upregulate
stem cell survival signaling including b-catenin, Notch1 and Survivin in response to radiation. Moreover, 3D spheres
generated from the 293T cells have increased expression of mesenchymal genes including vimentin, n-cadherin,
zeb1, snail and slug as well as pro-metastatic genes RhoC, Tenascin C and MTA1. In addition, microRNAs implicated
in self-renewal and metastases were markedly reduced in 3D spheres.
Conclusions: 293T cells exhibit a cancer stem cell-like phenotype when cultured as 3D spheres and represent an
important research tool for studying the molecular and biological mechanisms of cancer stem cells and for testing
and developing novel targets for cancer therapy.
Background
The cancer stem cell theory proposes that a subpopula-
tion of cells, the cancer stem cells, exist in solid tumors
as well as cancers of hematopoietic origin and constitute
a reservoir of self-sustaining cells with the exclusive
ability to self-renew and maintain the tumor. These can-
cer stem cells have the capacity to both divide and
expand the cancer stem cell pool and to differentiate
into the heterogeneous non-tumorigenic cancer cell
types that constitute the bulk of the cancer cells within
the tumor [1]. Cancer stem cells have been proposed to
play a role in tumorigenesis and metastasis [2-4] as well
as in resistance to radiation and chemotherapy [5-9].
Thus, it may be necessary to target and eliminate these
cells to eradicate cancers.
Cancer stem cells have been identified in a mounting
number of human malignancies. Using approaches
developed in the hematopoietic malignancies, Clarke
and colleagues demonstrated the existence of a subpo-
pulation of tumorigenic cells (or tumor-initiating cells),
isolated from breast cancer pleural effusions by limiting
dilution transplantation of CD44+/CD24-/lineage- cells
into the mammary fat pad of immunocompromised
mice [10]..Importantly, Dontu et al. adapted a sphere
culture system described in the central nervous system
[11] by growing primary breast epithelial cells in serum-
free medium containing EGF and FGF2 in suspension
culture and demonstrated enrichment of the tumor-
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any medium, provided the original work is properly cited.initiating population. This enriched population is suita-
ble to demonstrate in vitro self-renewal and multi-line-
age differentiation potential [12]. This assay has been
adapted to study cancer stem/progenitor cells in breast
cancer cell lines as well as in colon, brain and pancreatic
cancer tissues [11,13-18]. Another marker of the cancer
stem cell population was recently established by Gines-
tier et al. who showed that aldehyde dehydrogenase 1
(ALDH1)-positive cells from human breast tumors were
the tumorigenic cancer-initiating population [19]. High
ALDH activity has also been used to define cancer stem
cell populations in other solid tumors including colon,
liver and pancreatic cancers [20-22]. Numerous studies
suggest that cell lines can be useful in vitro tools to
study these populations, and at this time the percentage
of cancer stem cell markers has been characterized in
numerous cancer cell lines [15,17]. These efforts have
led to the use of appropriately selected cell lines rich in
the surrogate phenotypes to screen for agents that target
these cancer stem cell surrogates [23]; however the
number of lines expressing each of the surrogates
reported thus far is few.
We observed several key biologic features of pur-
ported cancer stem cells in human embryonic kidney
cells 293T (also designated HEK 293T), a widely used
cell line derived through the sheared Adenovirus 5
(Ad5) DNA transformation [24]. Most importantly,
tumors from these cells self-renew as evidenced by serial
xenograft passage through transplantation into the
cleared mammary fat pad continued over eight genera-
tions. Guan et al previously showed that primary HEK
239T cells form tumors that could be inhibited by
RbAP46 [25], and Shen et al. demonstrated that tumor
forming efficiency had increased with increasing passage
of these cells [26], but serial self-renewal has not been
reported. We hypothesized that these embryonic,
t u m o r i g e n i cc e l l sm a yb eu s e f u lt os t u d yc a n c e rs t e m
cells and add to the arsenal of cell lines with significant
cancer stem cell surrogate representation to facilitate
the study of targeted agents against this population.
Here we focused on the cancer stem cell surrogates
d e s c r i b e di nb r e a s tt u m o rm o d e l sa n dt r a n s p l a n t e d
tumor cells into the cleared mammary fatpads to exam-
ine in vivo tumor pathology. We report that 293T cell
readily form spheres that are enriched with cancer stem
cell surrogates ALDH1 and CD44+/CD24- cells and
express proteins associated with the epithelial-mesench-
ymal transition and stem cell developmental pathways.
They are also depleted in the microRNA that has been
implicated in cancer stem cell self-renewal. We propose
that this is a valuable cell line to study cancer stem cell
surrogates identified in human cancers as well as the
plasticity of transformed embryonic cells.
Results
293T cells form spheres in stem cell promoting culture
that are enriched in cancer stem cell markers
When 293T cells were transplanted into the cleared fat
pads of 3 week old SCID/Beige mice, all (10/10) glands
developed tumors at 14 days. These tumors were serially
passaged through six transplant generations and are
phenotypically stable. Hemotoxylin and eosin staining
was performed and examined by a clinical breast pathol-
ogist. Histology was indistinguishable from high grade
adenocarcinoma of the breast (although the histological
appearance of high grade poorly differentiated tumor is
not specific only to breast tumors). All tumors had
evident tumor vasculature and expressed VEGF
(Figure 1A). Necropsy was performed on all mice at the
time of sacrifice and no metastatic disease was identified
in solid organs. Bone marrow aspirates from generation
two mice were negative for malignant cells. Tumors
were negative for the epithelial markers e-cadherin and
cytokeratin 19 while they were positive for vimentin and
b-catenin (Figure 1B), features associated with poorly
differentiated tumors.
Given the in vivo observation that 293T tumors seri-
ally transplant and self-renew, we characterized the cell
line for its cancer stem cell properties. 293T cells seeded
in the self-renewal promoting suspension culture condi-
t i o n sf o r m e dr o u n ds p h e r e so fv a r y i n gs i z e sa n dt h e s e
spheres can be passaged to give a higher proportion of
secondary spheres (Figure 2A, B). To characterize
further the stem cell component of the spheres, flow
cytometry was used to measure cells bearing the tumor-
initiating phenotype CD44+/CD24- and ALDH activity.
As shown in Figures 2C and 2D, CD44+/CD24- cells
represent an average of 4% ± 2% cells in 2D culture
and 22% ± 10% cells in 3D culture (5-fold increase,
P = 0.003) and 3D spheres showed a 7-fold ALDH activ-
ity compared to 2D cells (6% vs. 43%). Further, tumors
from 293T were dissociated into single cells and
assessed for cancer stem cell surrogates using fresh cells
or cells propagated under sphere forming conditions.
CD44+/CD24- cells comprised an average of 0.25%
(N = 2) from primary tumors and 16.4% (N = 4) from
tumor derived sphere culture, a 65-fold increase. ALDH
increased comparably from 0.2% in the primary tumor
to an average 17.5%. Individual tumor data are summar-
ized in table 1.
Using RT-PCR to examine the expression of embryo-
nic stem cell gene mRNAs in cells derived from spheres
(3D) and compare them to cells maintained as adherent
monolayer culture we found 3D spheres selectively
expressed embryonic stem cell transcription factors
Oct4, Nanog, Sox2 and Klf4 (Figure 3A) genes whose
expression was associated with reprogramming of adult
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We also examined stem cell signaling and downstream
effectors in 2D versus 3D culture as a surrogate compar-
ison of differentiated versus progenitor enriched culture.
b-catenin, survivin and Rex-1 were upregulated in 3D
culture (Figure 3B) in protein lysates obtained from
293T cells cultured as spheres vs. monolayer cells. Rex-
1 is a target gene of the stemness marker Oct4 and thus
its expression in the 3D spheres could be a functional
readout of Oct4 activity. Moreover, the self-renewal fea-
ture of the 293T spheres was assessed using the label
retaining fluorescent membrane dye, PKH-26. Self-
renewal in sphere culture is expected to generate both
heterogeneous spheres containing self-renewing cells
and committed lineage specific spheres derived from
self-renewing cells. In spheres from 293T cells using
PKH-26 label retention as a marker for quiescent cells,
spheres were identified after 4 passages that retain a sin-
gle label-retaining cell (Figure 3C). Furthermore, immu-
nostaining of 293T cells showed that the majority of
cells stain with the basal cytokeratin K14 while few cells
stain for the luminal marker K18 (Figure 3D) suggesting
that 293T cells have early differentiating cell
characteristics.
Spheres generated from 293T cells are resistant to
therapy
Following the observation that 293T cells from the
sphere culture are enriched in cancer stem cell markers,
we examined differences in resistance to radiation- or
chemo-therapy between 2D and 3D cultures. Using the
3D mammosphere/2D clonogenic assay method that has
been recently demonstrated by our lab [16], we found
that cells in 3D culture are significantly more resistant
to radiation than the same cells grown in 2D culture
(Figure 4A) and second generation spheres are more
resistant than primary spheres (data not shown). More-
over, b-catenin, Notch and survivin were all upregulated
in 3D culture cells 48 hours after 4 Gy of irradiation
compared to the unirradiated cells while Numb, a nega-
tive regulator of Notch, is downregulated with radiation
(Figure 4B). Similarly Retinoic acid, a compound that
has been used as a cancer chemotherapeutic agent, sig-
nificantly reduced the number of colonies in monolayer
culture but did not decrease sphere formation (Figure
4C) indicating that the 3D cells can be resistant to che-
motherapeutic agents.
Epithelial-Mesenchymal Transition (EMT) and pro-
metastatic genes are upregulated in 3D spheres of
293T cells
In view of the recent findings that EMT increases the
stem cell population in normal and malignant mammary
epithelial cells as well as in pancreatic and colorectal
cancer cells [13,18], we investigated EMT gene expres-
sion patterns by western blot in the 2D versus 3D cul-
ture as a surrogate comparison of differentiated versus
stem/progenitor enriched culture. Figure 5A shows that
the mesenchymal gene markers n-cadherin, vimentin
and zeb1 were upregulated in 293T cells cultured in
Figure 1 Transplantation of 293T cells into the cleared mammary fat pad of immunocompromised mice yields serially transplanting
tumors. A) Skin overlying grossly involved tumor is necrotic and abnormal and tumors demonstrate gross tumor vasculature and are diffusely
positive for vascular endothelial growth factor (VEGF). B) By immunohistochemical analysis tumor xenografts are strongly vimentin positive,
E-cadherin negative and beta-catenin positive at the membrane while K19, an epithelial marker is completely negative.
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2D culture conditions. Snail and slug, other EMT genes,
were also upregulated in the 3D culture compared to
the 2D with RT-PCR (Figure 5B).
We also assessed differences in 2D vs. 3D for the
expression pattern of genes implicated in promoting
invasion, migration and metastasis of cancer cells. RhoC
is upregulated in 3D spheres of 293T cells as compared
to monolayer cells (Figure 5C). RhoC has been identified
as an important player in metastasis [30,31] and its
expression correlates with metastatic spread of various
types of carcinomas [32,33]. Similarly, Tenascin C and
Figure 2 293T cells form spheres in suspension culture that exhibit cancer stem cell phenotype. A, B) Sphere formation in 293T cells
seeded in self renewal promoting suspension culture conditions. Passage of 293T spheres gives rise to higher proportion of secondary spheres.
C) Flow cytometric analysis of expression of CD24 and CD44 in 293T cells. Cells were cultured under adherent (2D) or tumor-initiating cells
enrichment condition (3D). There is an increase of CD44+/CD24- population in cells cultured in 3D vs. 2D culture conditions. D) Flow cytometric
analysis of ALDH activity showed that the 3D culture condition enriches for ALDH-positive cells compared to the 2D culture of 293T cells.
Table 1 Characterizing breast cancer stem cell surrogates in spheres derived from 293T tumors
Tumor ID CD44+/CD24- CD44-/CD24+ CD44+/CD24+ CD44-/CD24- ALDH+/-DEAB
293T 0.4 0.2 0 98.6 0.2
293T 0.1 37.4 0 52.6 0.2
293T Sphere -1 5.5 2.3 0 92.4 24.6
293T Sphere -2 17.4 1 0 80.2 27.7
293T Sphere -3 24.2 0.2 0 72.1 12.1
293T Sphere -4 18.3 3.2 0.1 78.5 5.6
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migration of cancer cells [34-36] were upregulated in
3D vs. 2D 293T cells (Figure 5C).
MicroRNAs implicated in self renewal and metastasis are
markedly reduced in 3D spheres
Following the findings that 3D spheres from 293T cells
exhibit the cancer stem cell phenotype as well as express
EMT and pro-metastatic genes, we examined for differ-
ences in the expression of microRNAs that are associated
with self-renewal and metastases. It has been demonstrated
that the let-7 microRNA family regulates the self-renewal of
breast cancer stem cells [37]. In line with these findings, we
found that Let-7 microRNAs are highly reduced in 3D stem
cell promoting cultures in 293T cells compared to the 2D
monolayer cells (Figure 6A) while two known Let-7 target
genes, H-Ras and HMGA2, were upregulated in 3D vs. 2D
(Figure 6B). Likewise, the microRNAs miR-200c, miR-205,
miR-206 and miR-335 previously reported to be involved in
invasion and metastasis [38-40] are reduced in the 3D stem
cell promoting cultures in 293T cells. Moreover, miR-138,
miR-203 and miR-363 previously uncharacterized in metas-
tases are also downregulated in 3D vs. 2D cells (Figure 6C).
Table 2 summarizes the miRNAs downregulated in 3D cul-
ture of 293T cells and the validation of predicted genes by
western blot or RT-PCR.
Discussion
We propose 293T is a valuable tool to study cancer
stem/progenitor features in that it rapidly generates
both spheres and tumors that are readily serially pas-
saged, and maintains significant populations of the
tumor-initiating phenotypes described in the cancer
stem cell literature. In this study, we observed that
transplanting 293T cells into the cleared mammary fat
pads of immunocompromised mice resulted in serially
transplantable rapidly growing tumors. Propagation of
spheres from tumor tissue or directly from the cell line
enriched for ALDH activity and CD44+/CD24- markers
and expression of EMT markers as well as genes that
promote stem cell survival. Papers characterizing similar
features in existing cancer cell lines have demonstrated
a wide range in each of the purported cancer stem cell
populations in these lines making the lines available to
screen simultaneously against each surrogate limited.
The 293T cell line was developed through transforma-
tion of human embryonic kidney cells using the sheared
Adenovirus 5 (Ad5) DNA [24]. It expresses genes per-
mitting the replication of E1-deficient, non-replicating
adeno and adeno-associated viral vectors leading to
their common use of generating viral vectors for labora-
tory and gene therapy use. From the initial report in
1977, the transformation was surprisingly inefficient.
Figure 3 Spheres from 293T cells express embryonic transcription factors implicated in self-renewal. A) RT-PCR demonstrated higher
expression of embryonic stem cell specific genes including Oct4, Nanog, Sox2 and Klf4 in 3D spheres of 293T cells but no expression was
observed in 2D monolayer cells. B) Genes implicated in promoting survival of cancer stem cells such as b-catenin, survivin and Rex-1 were
upregulated in 3D spheres vs. 2D monolayer cells. C) Serial passage for more than 4 weeks without additional PKH-26 label (Red) reveals serial
dilution to a single long term label-retaining cell per sphere suggestive of asymmetric self-renewal. D) Immunocytochemistry reveals the majority
of 293T cells as keratin 14 positive.
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only one of twenty cultures forming a single colony in
each case. Attempts to isolate these were not successful,
however and a single transformed colony was observed
in one dish not discarded 75 days after the original
experiment. Partial serum starvation (2%) was used to
select for the transformed phenotype and eventually the
isolated culture was expanded. The culture was reported
to contain cells of several morphologies of generally
epitheliod appearing cells. Injection of 2 × 10
7 cells sub-
cutaneously into nude mice yielded no tumors after
6-8 weeks. Re-injection at that time resulted in tumors
15-20 weeks after the first injection in 3/20 animals. In
stark contrast, Shen et al [26] report that in cells pas-
saged greater than 65 times, the tumorgenicity increases
to 100% with tumors formed in two weeks. We have
reproduced these findings with 100% tumor formation
when injected into the cleared mammary fat pads of
immunocompromised mice and further report that
these tumors are serially transplantable with similarly
aggressive biology and resembled poorly differentiated,
high grade malignant primary tumor on histology. It’s
noteworthy that there is controversy on the origins of
HEK 293T cells as it has been assumed that they were
generated by transformation of either a fibroblastic,
endothelial or epithelial cell all of which are abundant
in kidney. However, the fact that the cells originated
from cultured kidney cells does not say much about the
exact cellular origin of the HEK 293T, as embryonic
kidney cultures may contain small numbers of almost
all cell types of the body. In fact, a study by Graham
and colleagues provided evidence that these cells and
several other human cell lines generated by adenovirus
transformation of human embryonic kidney cells have
many neuronal progenitor properties, suggesting that
the adenovirus was taken up and transformed a neuro-
nal lineage cell in the original kidney culture [41]. Thus,
the spheres generated from 293T cells under stem-cell
promoting culture condition may have features observed
in neurospheres.
Figure 4 Spheres generated from 293T cells are resistant to therapy. A) Clonogenic/mammosphere formation assay of 293T cells cultured
under 2D or 3D promoting culture conditions. Cells in 3D are more resistant to radiation than cells grown in 2D. Cells were grown in 2D or 3D
culture conditions and irradiated with single, increasing doses (0, 2, 4, 6 Gy) of radiation. B) Upregulation of genes implicated in radioresistance
including b-catenin, Notch and Survivin in 3D cells 48 hours after 4 Gy of irradiation. C) 3D cultured cells are also more resistant to
chemotherapeutic drugs like retinoic acid compared to 2D. Similar results were obtained with Taxol (data not shown). Indicated concentrations
of drugs were added to the media until the number of colonies or spheres were counted.
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explored known cancer stem cell surrogates and signal-
ing pathways described in various cancer studies and
confirm this cell line faithfully recapitulates the
described biology of purported cancer stem cells. Pre-
vious studies showed that nuclear and cytoplasmic
extracts from undifferentiated cells can reprogram 293T
cells into a stem cell-like phenotype with activation of
embryonic stem cell genes and outgrowth of spherical
structures. As a result of treatment of 293T monolayer
cells with embryonic carcinoma cell extract, spherical
colonies of 293T cells develop and induce Oct4 gene
expression which in turn induces the expression several
Oct4-responsive genes like Sox2, Nanog and Rex1
[42-44]. Consistent with these findings, our study has
found activation of the pluripotency genes as well as for-
mation of spheres in suspension culture suggesting that
the stem cell promoting culture condition promotes
dedifferentiation. The notion that cells with properties
of cancer stem cells can be generated from differentiated
somatic cells has been proposed in a recent study by
Dean and colleagues [45]. These authors demonstrated
that culturing retinoblastoma-deficient mouse embryo-
nic fibroblasts in suspension culture form spherical
structures, re-express embryonic stem cell markers and
at least a subset of this population adopts characteristics
of cancer stem cells. Likewise, recent accounts from
Weinberg’s group [46] and others [47] suggest the possi-
bility of reversion or reprogramming of differentiated
cancer cells into cancer stem cells.
Several studies from our lab have shown that breast
cancer stem/progenitor cells are resistant to radiation
compared to bulk, differentiated cells [9,16,48,49]. Phil-
lips and colleagues also demonstrated the radioresis-
tance of putative breast cancer stem/progenitor cells by
comparing the radiosensitivity of cells derived from the
CD44+/CD24-subpopulation of MCF-7 cell line grown
as spheres vs. monolayers [8]. The resistance of cancer
stem cells to radiation has been shown to be mediated
by the b-catenin [9,49] or Notch signaling pathway [8].
Similar findings were reported in brain tumors demon-
strating that CD133-expressing glioma stem cells are
relatively resistant to radiation in vivo and in culture
compared to non-stem cells [50]. Likewise, in our study
the stem cell-enriched population from the 293T cells is
much more resistant and with increased expression of
b-catenin and Notch1 compared to the adherent popu-
lation. Moreover, a study by Li et al demonstrated that
the percentage of cancer stem cells, assayed by mammo-
sphere forming efficiency, was significantly increased
after chemotherapy highlighting the chemoresistant nat-
ure of cancer stem cells [7].
The molecular basis underlying the EMT process
involves multiple changes in expression and function of
proteins that include vimentin and cadherins [51-53].
Acquired expression of vimentin by carcinoma cells often
symbolizes mesenchymal-like cell transformation [52]
w h i l el o s so fE - c a d h e r i no rg a i no fN - c a d h e r i no nt u m o r
cell surface is frequently observed in malignant carcino-
mas and also correlated with enhanced aggressiveness
and dedifferentiation [51]. Recent studies have demon-
strated that induction of EMT using Twist and Snail in
transformed mammary epithelial cells creates popula-
tions that are highly enriched for cancer stem cells as
evidenced by increased CD44+/CD24- expression, mam-
mosphere formation and tumor seeding ability [18].
These cells showed attributes of mesenchymal phenotype
including expression of vimentin, fibronectin and n-cad-
herin. Similarly, in a recent study in pancreatic cell lines
the knockdown Zeb1, another EMT-inducer, affected not
only the initial formation of spheres but also led to
reduction of sphere numbers in subsequent generations
indicating its role in self-renewal and maintenance of the
stem cell phenotype[13]. In our current study, we found
higher expression of these EMT transcription factors in
spheres from 293T cells vs. monolayer cells in line with
the stem cell properties of 293T spheres.
MicroRNAs are emerging as important regulators of
cellular differentiation and EMT. Recent findings have
associated let-7 microRNAs with stem cell maintenance
and loss of let-7 in cancer has been reported to cause ded-
ifferentiation and self-renewal of breast cancer cells [37].
Consistent with our finding that the 293T spheres have
markedly reduced Let-7 expression and increased H-ras
Figure 5 EMT and pro-metastatic genes are upregulated in 3D
spheres of 293T cells. A) 293T spheres show upregulation of
markers of the mesenchymal phenotype in the epithelial-
mesenchymal transition such as higher n-cadherin, vimentin, and
zeb-1 and low E-cadherin compared to 2D cells. B) RT-PCR
demonstrated higher expression of EMT promoting genes Snail and
Slug in 3D sphere culture vs. 2D monolayer culture. C) Western blot
demonstrated upregulation of known proteins important in
promoting metastasis such as RhoC, Tenascin-C and MTA1 in 3D
spheres compared to 2D culture.
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showed that cancer stem cell population have markedly
reduced let-7 and increased H-ras and HMGA2 expres-
sion. By expressing let-7 in cancer stem cells, the authors
also found that let-7 regulates self renewal, multipotent
differentiation, and the ability to form tumors [37]. Several
recent studies have identified the miR-200 family and
miR-205 as key regulators of EMT and enforcers of the
epithelial phenotype of cancer cells [38,40]. MiR-200 was
found to directly target the mRNA of the E-cadherin tran-
scriptional repressors Zeb1 and Zeb2. While ectopic
expression of miR-200 caused up-regulation of E-cadherin
in cancer cell lines and reduced their motility, its inhibi-
tion reduced E-cadherin expression, increased expression
of vimentin and induced EMT [40]. Another microRNA,
miR-335, has been identified as metastasis suppressor
microRNA in human breast cancer [39]. It inhibits meta-
static cell invasion and migration through targeting of the
progenitor cell transcription factor Sox4 and extracellular
matrix component tenascin C. Moreover, the loss of
expression of this microRNA is associated with poor distal
metastasis-free survival [39].
Conclusions
293T cells readily form spheres that are enriched with
cancer stem cell surrogates ALDH1 and CD44+/CD24-
and express the proteins associated with the epithelial-
mesenchymal transition and stem cell developmental
Figure 6 MicroRNAs implicated in self-renewal and metastases are markedly reduced in 3D spheres. A) Higher expression of relative Let-
7 microRNA levels was seen in 2D vs. 3D sphere culture. RNA was extracted from 293T cells cultured in 2D and 3D conditions and subjected to
real time PCR using miRNA primers from Ambion. B) H-Ras and HMGA2, two known targets of Let-7 microRNAs, were expressed higher in 3D
than 2D cells by western blot. C) MicroRNAs known to regulate EMT are expressed at very low levels in 3D culture. RNA was extracted from
293T cells cultured in 2D and 3D conditions and subjected to quantitative PCRarray from SABiosciences.
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has been implicated in cancer stem cell self-renewal. Of
particular interest, these cells passage readily on serial
transplant into the cleared mammary fat pad of immu-
nocompromised mice. We propose that this is a valuable
cell line to study the cancer stem cell surrogates identi-
fied in human breast cancer as well as the plasticity of
transformed embryonic cells.
Methods
Cell culture
For sphere formation, 293T cells were placed in ultralow
attachment dishes (Corning, NY) in mammosphere
media as previously described by Dontu et al. [12].
Briefly, single cells were seeded in 6-well ultralow
attachment plates (Corning, NY) in serum free MEM
media supplemented with 20 ng/ml bFGF, 20 ng/ml
EGF, and B27 (Invitrogen). Adherent 293T cells were
grown on standard tissue culture plate in growth media
that contains DMEM with 10% fetal bovine serum and
penicillin-streptomycin.
RT-PCR and miRNA analysis
Total RNA was isolated from cells 2D monolayer and 3D
spheres with TRIzol reagent according to the manufac-
ture’s protocol. After treatment with DNase I (Ambion),
two micrograms of the RNA samples were reverse-tran-
scribed with random hexamers using Super Script III
First-Strand Synthesis System from Invitrogen. Control
reactions excluded reverse transcriptase. PCR was done
with aliquots of the cDNA samples at the annealing tem-
perature 60°C with the following primers: Oct4 forward
5′-ccagtatcgagaaccgagtgag-3′,r e v e r s e5 ′-gcatagtcgctgctt-
gatcg-3′;N a n o gf o r w a r d5 ′-gatgcctcacacggagactg-3′,
reverse 5′-gctggggtaggtaggtgctg-3′; Sox2 forward 5′-tcca-
cactcacgcaaaaacc-3′,r e v e r s e5 ′-ttgcaaacttcctgcaaagc-3′;
Klf4 forward 5′-ttctcacctgtgtgggttcg-3′, reverse 5′-
cctgggtcttgaggaagtgc-3′; Snail forward 5′-cggaagcctaacta-
cagcgag-3′,r e v e r s e5 ′-cttggcctcagagagctgg-3′;s l u g
forward 5′-gatgcatattcggacccacac-3′, reverse 5′-cctcatgtt
tgtgcaggagag-3′; Gapdh forward 5′-cacccagaagactgtg-
gatgg-3′, reverse 5′-ttctagacggcaggtcaggtc-3′. For micro-
RNAs, small RNAs were extracted using a mirVana
miRNA isolation kit (Ambion, Austin, TX) following the
manufacture′s protocol. Two micrograms of the total
RNA sample was reverse-transcribed with RT miRNA
First Strand Kit (SABiosciences, Frederick, MD). The
cDNA was mixed with SYBR Green/ROX qPCR Master
Mix and the mixture was added into a 96-well miRNA
PCR Array (SABiosciences) that included primer pairs
for 88 human miRNAs. PCR was performed on 7300
Real-Time PCR equipment (Applied Biosystems, Foster
city, CA). Threshold cycle (Ct) for each miRNA was
extracted using SDS2.3 software (Applied Biosystems)
and data was analyzed using an Excel-based data analysis
system (SA Bioscencies) that is based on the ΔΔCt
method. Normalization of the raw data was made to one
or more of the housekeeping genes in the Array.
Immunoblotting
Cell extracts were prepared from 2D monolayer and 3D
sphere cultures of 293T cells using cell lysis buffer (Cell
Signaling, MA), supplemented with protease inhibitor
(1 mM phenylmethanesulfonyl fluoride, PMSF). Protein
concentrations were determined using the Bio-Rad Pro-
tein Assay (Bio-rad, CA) and 40 ug of each sample was
separated using 4-20% Tris-HCl polyacrylamide gel
(Invitrogen, CA) and transferred onto a PVDF mem-
brane from Bio-Rad. The membranes were blocked in
5% milk powder in TBS-T for ~1 hour and were then
incubated with the following primary antibodies: anti-E-
cadherin, anti-N-cadherin, and anti-Vimentin (BD
Table 2 MicroRNAs downregulated in 3D culture and their predicted target genes
miRNAs Predicted target genes (related to invasion and metastasis) Targets validated in 3D culture
miR-138 Vimentin Yes
RhoC Yes
Sox-4 No
Zeb2 No
miR-363 Snail Yes
Zeb-2 No
miR-206 Slug Yes
miR-200c Zeb-1 Yes
miR-203 Slug Yes
TGFb3 No
miR-205 Zeb-2 No
miR-335 TNC Yes
Sox-4 No
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catenin and anti-survivin (Cell Signal); and anti-notch 1
(Santa Cruz). Membranes were washed three times and
incubated with the corresponding secondary antibody
conjugated with a horseradish peroxidase in 5% nonfat
milk at room temperature. After incubation with sec-
ondary antibody, the membranes were washed three
times and immunoreactivity was detected by enhanced
chemiluminescence. Anti-actin and anti-vincullin
(Sigma) antibodies were used as loading controls.
Flow Cytometry
For analyzing the CD44/CD24 subpopulation, 293T cells
cultured under sphere and adherent conditions were
harvested with 10 mM EDTA, centrifuged and resus-
pended in phosphate buffered saline (PBS) (10
5 cells/
ml). They were then incubated with FITC-conjugated
CD44 and PE-conjugated CD24 antibodies (BD Bios-
ciences, San Diego, CA, USA) for 30 minutes at concen-
trations recommended by the manufacturer. Cells
incubated in PBS, FITC or PE alone served as controls.
Cell analysis for the expression of CD44 and CD24 was
performed using a Beckman Coulter machine and the
data files were analyzed using FlowJo software (Treestar,
Ashland, OR). For aldehyde dehydrogenase (ALDH)
activity assay, the Aldefluor kit (Lonza) was used
according to the manufacturer’s instructions. Briefly,
about 5 × 10
5 2D monolayer and 3D sphere cultures of
293T cells were suspended in Aldefluor assay buffer
containing ALDH substrate and incubated for 30 min at
37°C. As a negative control for each sample, a sample of
cells was incubated with 50 mmol/L of the specific
ALDH inhibitor diethylaminobenzaldehyde (DEAB).
Aldefluor fluorescence was excited at 488 nm and fluor-
escence emission was detected using a Beckman Coulter
m a c h i n ea n dt h ed a t af i l e sw e r ea n a l y z e du s i n gF l o w J o
software (Treestar, Ashland, OR).
Label retention assay
Cells were trypsinized, resuspendend in PBS, and labeled
with PKH26 (Sigma). Labeled cells were plated in sus-
pension in ultralow attachment plates in mammosphere
culture media [12]. After 7 days, spheres were harvested,
enzymatically dissociated and subjected to serial pas-
sages without further addition of PKH26. Intact spheres
from the serial passages were subjected to PKH26 stain-
ing and were viewed by confocal microscopy.
Clonogenic assay/3D sphere formation assay
This was conducted as we previously described [16].
Briefly, monolayer cultures of 293T cells were trypsi-
nized into single cells and were seeded into individual
wells of a 6-well tissue culture plate (for 2D) or ultralow
attachment plates (for 3D). Both 2D and 3D 6-well
plates containing seeded single cells were exposed to
increasing doses of irradiation 4 hrs after plating. 2D
plates were incubated for 14 days and colonies were
stained with crystal violet while 3D cells were incubated
in mammosphere media for 7 days, the spheres were
stained with MTT and those with a size of 50 uM were
counted using a Gelcount colony counter (Oxford
Optronix, Oxford, UK). Survival curves were generated
using Sigmaplot 8.0.
Transplantation
2×10
6 fresh cells from monolayer culture were mixed
with matrigel (1:1), and injected directly into the epithe-
lium-free cleared fat pads of three-week-old female
SCID/Beige recipient mice [54]. Mice were palpated
weekly and tumor growth measured using calipers.
When tumors reached 10 mm in diameter, they were
collected for further analysis. Fresh tumor fragments
were minced into 1 mm
3 fragments, and re-transplanted
into new SCID/Beige hosts for subsequent transplant
generations, and expanded as transplantable tumor
tissue lines.
Immunostaining procedure
Immunostaining was performed in a autostainer (Vision
Biosystems, Norwell, MA) using Bond max protocol.
The primary antibodies that were used in the study
included E-cadherin (HECD-1, 1:100, Zymed/Invitro-
gen), b-catenin (1:500, BD Biosciences), VEGF (A-20;
1:10, Santa Cruz Biotechnology) and Keratin 19 (RCK
108, 1:50, Dako). The slides were dewaxed, rinsed with
alcohol for dehydration and antigen retrieval was per-
formed using citrate buffer. The slides were then treated
with 3% H2O2, and primary antibodies were applied on
t h et i s s u es e c t i o n sa n di n c u bated for 10 minutes. The
slides were subsequently treated with Poly-horseradish
peroxidase, anti-mouse/rabbit IgGs. For visualization of
the signal, 3, 3′diaminobenzidine (DAB) was used as the
chromogen. Hematoxylin counterstaining was used for
visualization of the nucleus.
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